Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588562 · ClinicalTrials.gov registry record
Rare Kidney Stone Consortium Patient Registry
A clinical trial of Dent Disease and Cystinuria, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 730
- Enrollment target
- 4
- Study locations
NCT00588562: Recruiting study of Dent Disease and Cystinuria, sponsored by Mayo Clinic.
NCT00588562 is a study of Dent Disease and Cystinuria that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 730 participants, above the 595-participant average among 4 other Dent Disease trials with a reported enrollment target (23% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588562, a study of Dent Disease and Cystinuria, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 730 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria (PH), Dent disease, Cystinuria and APRT deficiency. This information will create a registry that will help us to compare similarities and differences in patients and their symptoms. The more patients we are able to enter into the registry, the more we will be able to understand the Primary Hyperoxalurias,Dent disease, cystinuria and APRT and learn better ways of caring for patients with these diseases.
Primary Outcome
The patient Registries will expand knowledge of the clinical expression of these disease by systematically accumulating and analyzing information regarding a larger number of patients than have been studied to date.
Conditions Studied
Study Locations (4)
Minnesota
- Dent Disease Registry -Mayo Clinic - Rochester
- Primary Hyperoxaluria Registry - Mayo Clinic - Rochester
New York
- Cystinuria Registry - New York University - New York
Other
- APRT Registry - Landspitali Universtiy Hospital - Reykjavik
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 730 participants |
| Start Date | 2003-07 |
| Est. Completion | 2028-06 |
What NCT00588562 shows while recruiting
NCT00588562 is an observational study that tracks outcomes without assigning an intervention. The registered 730 participants enrollment target is mid-sized for trials with a published cap, above the 595-participant average among 4 other Dent Disease trials with a reported enrollment target (23% higher).
The record links to 4 conditions, with Dent Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00588562 reports a single indexed study location in Minnesota, New York, Other.
Frequently Asked Questions
What is clinical trial NCT00588562 about?
NCT00588562 is a clinical study titled "Rare Kidney Stone Consortium Patient Registry". The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria (PH), Dent disease, Cystinuria and APRT deficiency. This information will create a registry that will help us to compare similarities and differences in p...
What is the current status of trial NCT00588562?
This trial is currently recruiting. The enrollment target is 730 participants. The study started on 2003-07. Estimated completion is 2028-06.
What conditions does trial NCT00588562 study?
This clinical trial studies the following conditions: Dent Disease, Cystinuria, Primary Hyperoxaluria, APRT Deficiency.
Who is sponsoring clinical trial NCT00588562?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00588562 being conducted?
This trial has 4 study locations across Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dent Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03232918 · 730 participants · Phase 4
Oxytocin and Fetal Heart Rate Changes
- NCT05548283 · 730 participants · Phase 4
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- NCT07312162 · 730 participants
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia